Work

An Indications, Mechanism of Action, Administration, Adverse Effects, Contra Indications, Toxicity and Health Care Team Outcomes of Selective Beta - 1 Blockers

Year: 2026

Type: article

Abstract: Among the cardio-selective beta-1-blockers are nebivolol, metoprolol, acebutolol, esmolol, betaxolol, bisoprolol, and atenolol. Heart failure, post-myocardial infarction, hypertension, chronic stable angina, and decreased left ventricular function following a recent myocardial infarction are among the conditions for which beta-1-selective blockers are FDA-approved. Preventing migraines, treating arrhythmias, reducing tremors, and treating the symptoms of anxiety disorders are among the non-FDA-approved use. Reduced morbidity and mortality following myocardial infarction is associated with their use. Beta-1 blocker therapy lowers the risk of congestive heart failure, coronary artery disease, and stroke. In order for providers to guide patient therapy regarding the treatment of indicated disorders as part of the interprofessional team, this activity provides information on the indications, mechanisms of action, administration techniques, significant adverse effects, contraindications, and monitoring of selective beta-1 antagonists. It also provides a foundation for optimal utilization based on current knowledge.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.19841903

Authors: Ramanjaneyulu D.V., Satyanarayana Murthy S., Srinivas G., Muralinath E., Guruprasad M., Hari Kiran M., Shaik Mahabooob Basha, Kundara Giridhar Reddy, Kasireddy Gauthami, Mopoori Kalyan, Sai Charan B., Sainath Reddy T., Ramesh U., Rahul P., Rajitha V.

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7157235102

FWCI:

Cites:

Cited by:

Related to: